Chronic obstructive pulmonary disease (COPD) market Insights: Rising prevalence of COPD due to aging and smoking.
5don MSN
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
News Medical on MSN5d
The impact of fall-risk medications on injuries in COPD patientsPeople with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
A Midtown-based medical device startup is carving a niche in the growing field of treatments to address chronic lung disease.
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new study.
Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from ...
TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback